Astellas and the Institute of Medical Science at the University of Tokyo are expanding the range of diseases that can be covered by their rice-based oral vaccine, MucoRice.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|